Clinical Trial Update: Pharmacogenetic Study of Methylphenidate in Attention Deficit/Hyperactivity Disorder(ADHD) [Phase 4]

View source ↗

Summary

A Phase 4 pharmacogenetic study evaluating how genetic factors influence response to methylphenidate in Attention Deficit Hyperactivity Disorder, with the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Hallym University Medical Center | Conditions: Attention Deficit Disorder With Hyperactivity, Methylphenidate | Phase 4 | Status: COMPLETED